Base to Base biotech podcast 57: Keeping drugs cool, and treatment resistant depression
ELREXFIO improves progression-free survival for patients with relapsed or refractory multiple myeloma
Aragen launches India’s first women-led chemistry synthesis laboratory
Vaccine strategy induces broadly neutralising HIV antibodies
FDA clearance for refractory systemic lupus erythematosus CAR-T cell therapy
Novel gene therapy for ALS cleared for trials in US and China
Positive phase 2 results from Stargardt disease study
Researchers re-engineer AI language model to target previously ‘undruggable’ disease proteins
Kexing Biopharm partners with IQVIA to expand globally
ThinkBio.Ai and UST partner to help biopharma and healthcare
ChronicleBio aims to accelerate breakthroughs for millions living with complex chronic conditions
Base to Base biotech podcast 22: A new treatment for dry AMD and tackling peanut allergies